Assignee
CANCER RES CAMPAIGN TECH
GB·53 granted patents·1 pending application·1,818 citations·filing 1989–2004
Top patents by PatentIndex Score
54 records- 0197US6130237ACondensed N-aclyindoles as antitumor agentsCANCER RES CAMPAIGN TECH·Filed 1999·Granted Oct 10, 2000·146 cites·18 claims
- 0295US5811454A4-amino-fluorobenzamides and their use as cytotoxic prodrugsCANCER RES CAMPAIGN TECH·Filed 1994·Granted Sep 22, 1998·58 cites·13 claims
- 0393US5728868AProdrugs of protein tyrosine kinase inhibitorsCANCER RES CAMPAIGN TECH·Filed 1994·Granted Mar 17, 1998·119 cites·3 claims
- 0493US5457130AEicosapentaenoic acid used to treat cachexiaCANCER RES CAMPAIGN TECH·Filed 1994·Granted Oct 10, 1995·191 cites·4 claims
- 0592US5281620ACompounds having antitumor and antibacterial propertiesCANCER RES CAMPAIGN TECH·Filed 1992·Granted Jan 25, 1994·48 cites·6 claims
- 0691US6303323B1Detection of dysplastic or neoplastic cells using anti-MCM5 antibodiesCANCER RES CAMPAIGN TECH·Filed 1998·Granted Oct 16, 2001·81 cites·21 claims
- 0790US7083983B2Inhibitors of the interaction between P53 and MDM2CANCER RES CAMPAIGN TECH·Filed 1997·Granted Aug 1, 2006·108 cites·15 claims
- 0888US5260291ATetrazine derivativesCANCER RES CAMPAIGN TECH·Filed 1991·Granted Nov 9, 1993·135 cites·33 claims
- 0984US6977298B2Tricyclic inhibitors of poly(ADP-ribose) polymerasesCANCER RES CAMPAIGN TECH·Filed 2004·Granted Dec 20, 2005·16 cites·8 claims
- 1083US5929046APyrimidine and purine derivatives and their use in treating tumour cellsCANCER RES CAMPAIGN TECH·Filed 1995·Granted Jul 27, 1999·38 cites·19 claims
- 1183US5716990ADrug delivery systemsCANCER RES CAMPAIGN TECH·Filed 1996·Granted Feb 10, 1998·64 cites·6 claims
- 1281US6531097B1Measuring the concentration of a substanceCANCER RES CAMPAIGN TECH·Filed 2000·Granted Mar 11, 2003·34 cites·32 claims
- 1380US6303618B1Cyclin dependent kinase inhibiting purine derivativesCANCER RES CAMPAIGN TECH·Filed 2000·Granted Oct 16, 2001·17 cites·15 claims
- 1480US5876691AAntibody against carcionembryonic antigen (CEA)CANCER RES CAMPAIGN TECH·Filed 1994·Granted Mar 2, 1999·77 cites·23 claims
- 1580US5633158ABacterial nitroreductase for the reduction of CB 1954 and analogues thereof to a cytotoxic formCANCER RES CAMPAIGN TECH·Filed 1992·Granted May 27, 1997·25 cites·13 claims
- 1679US5869053A5T4 antigen from human trophoblastsCANCER RES CAMPAIGN TECH·Filed 1993·Granted Feb 9, 1999·64 cites·13 claims
- 1778US6165715AExpression systemsCANCER RES CAMPAIGN TECH·Filed 1996·Granted Dec 26, 2000·50 cites·35 claims
- 1875US5977065ABacterial nitroreductase for the reduction of CB1954 and analogues thereof to a cytotoxic formCANCER RES CAMPAIGN TECH·Filed 1998·Granted Nov 2, 1999·16 cites·11 claims
- 1974US6043228AO6 -substituted guanine derivatives, a process for their preparation and their use in treating tumor cellsCANCER RES CAMPAIGN TECH·Filed 1995·Granted Mar 28, 2000·26 cites·35 claims
- 2074US5780585ABacterial nitroreductase for the reduction of CB 1954 and analogues thereof to a cytotoxic formCANCER RES CAMPAIGN TECH·Filed 1995·Granted Jul 14, 1998·30 cites·8 claims
- 2173US5750782ANitroaniline derivatives and their use as anti-tumour agentsCANCER RES CAMPAIGN TECH·Filed 1996·Granted May 12, 1998·13 cites·4 claims
- 2272US6251933B1Seco precursors of cyclopropylindolines and their use as prodrugsCANCER RES CAMPAIGN TECH·Filed 1997·Granted Jun 26, 2001·17 cites·14 claims
- 2371US5958721AMethods for screening of substances for therapeutic activity and yeast for use thereinCANCER RES CAMPAIGN TECH·Filed 1994·Granted Sep 28, 1999·17 cites·39 claims
- 2470US6852755B1Nitrogen mustard compounds and prodrugs thereforCANCER RES CAMPAIGN TECH·Filed 2000·Granted Feb 8, 2005·4 cites·52 claims
- 2570US6066457AGlobal amplification of nucleic acidsCANCER RES CAMPAIGN TECH·Filed 1998·Granted May 23, 2000·31 cites·28 claims
- 2670US5843143ALight sourceCANCER RES CAMPAIGN TECH·Filed 1993·Granted Dec 1, 1998·101 cites·26 claims
- 2769US6005002ANitrogen mustard prodrugs with novel lipophilic protecting groups, and processes for their productionCANCER RES CAMPAIGN TECH·Filed 1996·Granted Dec 21, 1999·29 cites·10 claims
- 2869US5985909ACyclopropylindoles and their seco precursors, and their use as prodrugsCANCER RES CAMPAIGN TECH·Filed 1996·Granted Nov 16, 1999·14 cites·12 claims
- 2964US6034246A2-arylbenzazole compoundsCANCER RES CAMPAIGN TECH·Filed 1997·Granted Mar 7, 2000·29 cites·24 claims
- 3063US6020309APharmaceuticals based on papillomavirusesCANCER RES CAMPAIGN TECH·Filed 1994·Granted Feb 1, 2000·20 cites·7 claims
- 3161US6677345B1Cyclin dependent kinase inhibitorsCANCER RES CAMPAIGN TECH·Filed 2000·Granted Jan 13, 2004·1 cites·28 claims
- 3261US5385740ABiologically active material characterized by catabolic activity generally associated with cachexia-inducing tumors, preparations, production and uses thereofCANCER RES CAMPAIGN TECH·Filed 1992·Granted Jan 31, 1995·15 cites·3 claims
- 3360US5854244AMelamine derivatives for use in the treatment of cancerCANCER RES CAMPAIGN TECH·Filed 1996·Granted Dec 29, 1998·8 cites·8 claims
- 3459US5731304APotentiation of temozolomide in human tumour cellsCANCER RES CAMPAIGN TECH·Filed 1994·Granted Mar 24, 1998·30 cites·11 claims
- 3558US5571845ANitroaniline derivatives and their use as anti-tumour agentsCANCER RES CAMPAIGN TECH·Filed 1992·Granted Nov 5, 1996·6 cites·9 claims
- 3657US6174532B1L2 immunogenic peptides of papillomavirusCANCER RES CAMPAIGN TECH·Filed 1995·Granted Jan 16, 2001·22 cites·21 claims
- 3757US6096724APyrimidine derivatives and guanine derivatives, and their use in treating tumor cellsCANCER RES CAMPAIGN TECH·Filed 1998·Granted Aug 1, 2000·16 cites·34 claims
- 3855US6380157B1Method of treatment using papillomavirus L2 proteinCANCER RES CAMPAIGN TECH·Filed 1995·Granted Apr 30, 2002·8 cites·13 claims
- 3955US5874431ABenzazole compoundsCANCER RES CAMPAIGN TECH·Filed 1996·Granted Feb 23, 1999·27 cites·24 claims
- 4053US5219579ABiologically active material characterized by catabolic activity generally associated with cachexia-inducing tumors, preparations, production and uses thereofCANCER RES CAMPAIGN TECH·Filed 1989·Granted Jun 15, 1993·17 cites·9 claims
- 4152US2002136736A1Papillomavirus L2 proteinCANCER RES CAMPAIGN TECH·Filed 2002·Application pending·0 cites
- 4244US6004550AIntracellular expression of carboxypeptidase G2 in a nitrogen mustard prodrug systemCANCER RES CAMPAIGN TECH·Filed 1995·Granted Dec 21, 1999·3 cites·10 claims
- 4343US6124310AEnediyne compoundsCANCER RES CAMPAIGN TECH·Filed 1996·Granted Sep 26, 2000·13 cites·24 claims
- 4438US7018791B1Binding complexesCANCER RES CAMPAIGN TECH·Filed 1998·Granted Mar 28, 2006·6 cites·18 claims
- 4538US6025340ASurface expression of enzyme in gene directed prodrug therapyCANCER RES CAMPAIGN TECH·Filed 1995·Granted Feb 15, 2000·2 cites·23 claims
- 4638US5373092ADerivatives of hydroxymethoxy mandelic acid (HMMA), homovanillic acid (HVA), antibodies and labelled substances prepared therefrom, and immunoassays using theseCANCER RES CAMPAIGN TECH·Filed 1993·Granted Dec 13, 1994·9 cites·12 claims
- 4738US5266720ADerivatives of hydroxymethoxy mandelic acid (HMMA), homovanillic acid (HVA), antibodies and labelled substances prepared therefrom, and immunoassays using theseCANCER RES CAMPAIGN TECH·Filed 1990·Granted Nov 30, 1993·9 cites·4 claims
- 4836US6255070B1Folding protein complexesCANCER RES CAMPAIGN TECH·Filed 1995·Granted Jul 3, 2001·2 cites·50 claims
- 4933US5958682ABacterial nitroreductase gene-prodrug systemCANCER RES CAMPAIGN TECH·Filed 1994·Granted Sep 28, 1999·1 cites·14 claims
- 5031US5359120AImprovements relating to the production of prodrugsCANCER RES CAMPAIGN TECH·Filed 1989·Granted Oct 25, 1994·0 cites·9 claims
Showing the top 50 of 54 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when CANCER RES CAMPAIGN TECH files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →